Mucosal Impedance in Pediatric Population
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance in Pediatric Patients
Assessment of Esophageal Epithelium Integrity With Mucosal Impedance in Pediatric Patients
Sponsor study identifier
Secondary identifiers
observational
127
1 country
1
Study Start
August 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
September 2016
Actual (reported)Study Completion
September 2016
Actual (reported)Our hypothesis is that patients with GERD and/or Eosinophilic Esophagitis (EE) have lower esophageal impedance measurements when compared to patients who do not have GERD or EE.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 2016
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 14, 2014
Actual (reported)August 2014
Date type not reportedThis date has not been verified as actual or estimated.
December 19, 2014
Actual (reported)September 2016
Actual (reported)September 2016
Actual (reported)Number of Patients with GERD and/or Eosinophilic Esophagitis(EoE)
Mucosal impedance will be obtained during standard of care endoscopy and results will be available immediately. For those patients who may be undergoing ph monitoring as standard of care, those data will be compared to the mucosal impedance values obtained at bedside.
5 minutes
Mucosal impedance values correspond with histopathologic diagnosis in patients with EoE
5 minutes
Pediatric patients scheduled for standard of care EGD with biopsy also received measurement of mucosal impedance
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Pediatric patients of our Vanderbilt Pediatric Gastroenterology Clinic undergoing routine evaluation of dyspepsia with endoscopy that meet the inclusion/exclusion criteria as defined above.
Vanderbilt Children's Hospital
Nashville, Tennessee, 37232, United States
Mary Allyson Lowry, MD
Vanderbilt University Medical Center
Sari Acra, MD
Vanderbilt University Medical Center
Michael Vaezi, MD, PhD
Vanderbilt University Medical Center
127 participants (actual enrollment reported by the registry).
First Submitted
July 14, 2014
First Posted
December 19, 2014
Study Start
August 2014
Date type not reportedThis date has not been verified as actual or estimated.
An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)
Contact the study team to confirm eligibility.
Primary Completion
September 2016
Actual (reported)Study Completion
September 2016
Actual (reported)Last Updated
May 1, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: